The Biology and Genetics of IRF8 Deficiency

The immune system relies on a precise genetic blueprint to build its defenses. In partial IRF8 deficiency, a change in the IRF8 gene (Interferon Regulatory Factor 8) alters how the body produces the specialized cells that detect and fight germs ^[1]. Understanding the biology and genetics behind this condition helps explain why certain infections occur and how the disease may affect different family members.

The Role of IRF8: The Master Architect

The IRF8 gene provides instructions for making a transcription factor—a protein that acts like a master architect for the immune system ^[2]. It works by sitting on the DNA of developing blood cells and “turning on” the genes required to become monocytes and dendritic cells (DCs) ^[3].

At the same time, IRF8 acts as a “gatekeeper” that prevents too many cells from becoming neutrophils (a different type of white blood cell) ^[4]. When IRF8 isn’t working correctly, this balance shifts: the body may struggle to make enough dendritic cells while producing an unusually high number of neutrophils, a condition called neutrophilia ^[5][6].

Inheritance Patterns

The way IRF8 deficiency is passed through a family depends on the specific mutation. Humans have two copies of the IRF8 gene—one from each parent. The clinical phenotype depends on the specific molecular mechanism; zygosity alone does not perfectly establish whether a deficiency is partial or complete.

• Autosomal Dominant (AD): In this pattern, having a mutation in just one copy of the gene is often enough to cause the condition ^[6]. This is frequently seen in partial IRF8 deficiency. Some of these dominant mutations are dominant-negative, meaning the “broken” protein not only fails to work but also actively interferes with the healthy protein from the other gene copy ^[6]. However, dominant-negative effects apply to some variants rather than all.
• Autosomal Recessive (AR): This occurs when both copies of the IRF8 gene are mutated (biallelic) ^[5]. This typically leads to complete IRF8 deficiency, which is much more severe because there is no working architect to guide immune cell development ^[7]. However, some biallelic hypomorphic variants can also produce partial disease.

Because the dominant form is “partial,” parents who carry the mutation may have very mild symptoms or no symptoms at all, even though their child may experience more significant infections ^[6][8]. Family testing and a genetic counselor are needed to interpret recurrence risk and penetrance.

For Readers Who Want More Detail: Dendritic Cell Subsets

Dendritic cells are the “sentinels” of the immune system. They are not all the same; they exist in subsets, each with a different job. The following findings are emerging in research but are not a universally standardized clinical profile:

• pDCs (plasmacytoid DCs) and cDC1s (conventional DCs): These cells require a high “dose” of IRF8 to develop. In partial deficiency, research suggests these are often the first cells to disappear or be severely reduced ^[6][1].
• The DC2 to DC3 Shift: Normally, IRF8 helps produce DC2s. However, there is another group called DC3s that needs very little IRF8 to grow ^[1]. In partial deficiency, as the number of DC2s drops, the body may compensate by expanding the number of DC3s to take their place ^[1].

These findings are variant-, age-, and laboratory-gating-dependent. Only an experienced immunology laboratory can interpret these subsets accurately.

Distinguishing IRF8 from Other Conditions

Because IRF8 deficiency is rare, it can sometimes be confused with other immune disorders that cause similar symptoms ^[9].

Genetic testing, such as Whole Exome Sequencing (WES), is a key way to help confirm an IRF8 diagnosis and rule out these other possibilities, though WES can miss deep-intronic or regulatory variants ^[5][13]. Researching the specific “spelling error” in the gene allows your care team to understand exactly how the immune system’s blueprint has been altered ^[7].